IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-03-15
DOI
10.3389/fonc.2022.866014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Microfluidic System to Analyze the Effects of Interleukin 6 on Lymphatic Breast Cancer Metastasis
- (2021) Hyeon-Yeol Cho et al. Frontiers in Bioengineering and Biotechnology
- Targeting the IL-6/STAT3 Signalling Cascade to Reverse Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer
- (2021) Ho Tsoi et al. Cancers
- Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer
- (2021) Matthew Kearney et al. BREAST CANCER RESEARCH AND TREATMENT
- Nitric Oxide-Releasing Drug Glyceryl Trinitrate Targets JAK2/STAT3 Signaling, Migration and Invasion of Triple-Negative Breast Cancer Cells
- (2021) Sarra Bouaouiche et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cells
- (2021) Ksenia Magidey-Klein et al. Journal for ImmunoTherapy of Cancer
- The novel long noncoding RNA AU021063, induced by IL-6/Arid5a signaling, exacerbates breast cancer invasion and metastasis by stabilizing Trib3 and activating the Mek/Erk pathway
- (2021) Kishan Kumar Nyati et al. CANCER LETTERS
- The Effect of a Newly Synthesized Ferrocene Derivative AGAINST MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway
- (2020) Mitra Nourbakhsh et al. Anti-Cancer Agents in Medicinal Chemistry
- LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer
- (2020) Li Pan et al. BREAST CANCER RESEARCH AND TREATMENT
- CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer
- (2020) Michael S. Ball et al. Scientific Reports
- IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis
- (2020) Rasmus Siersbæk et al. CANCER CELL
- Pentadecanoic Acid, an Odd-Chain Fatty Acid, Suppresses the Stemness of MCF-7/SC Human Breast Cancer Stem-Like Cells through JAK2/STAT3 Signaling
- (2020) Ngoc Bao To et al. Nutrients
- EMT, cancer stem cells and autophagy; The three main axes of metastasis
- (2020) Ghader Babaei et al. BIOMEDICINE & PHARMACOTHERAPY
- Dihydrotanshinone-Induced NOX5 Activation Inhibits Breast Cancer Stem Cell through the ROS/Stat3 Signaling Pathway
- (2019) Su-Lim Kim et al. Oxidative Medicine and Cellular Longevity
- MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer
- (2019) Yueh-Shan Weng et al. Molecular Cancer
- Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis
- (2019) Patricia Barrionuevo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer
- (2019) Jilai Tian et al. BREAST CANCER RESEARCH AND TREATMENT
- 3-Deoxy-2β,16-dihydroxynagilactone E, a natural compound from Podocarpus nagi, preferentially inhibits JAK2/STAT3 signaling by allosterically interacting with the regulatory domain of JAK2 and induces apoptosis of cancer cells
- (2019) Hui Shan et al. ACTA PHARMACOLOGICA SINICA
- Discovery of fluorescent coumarin-benzo[b]thiophene 1, 1-dioxide conjugates as mitochondria-targeting antitumor STAT3 inhibitors
- (2019) Guiping Cai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Ilamycin C induces apoptosis and inhibits migration and invasion in triple-negative breast cancer by suppressing IL-6/STAT3 pathway
- (2019) Qing Xie et al. Journal of Hematology & Oncology
- Novel Galiellalactone Analogues Can Target STAT3 Phosphorylation and Cause Apoptosis in Triple-Negative Breast Cancer
- (2019) Hyejin Ko et al. Biomolecules
- Inhibition of Tyrosine-Phosphorylated STAT3 in Human Breast and Lung Cancer Cells by Manuka Honey is Mediated by Selective Antagonism of the IL-6 Receptor
- (2019) Priyanka Aryappalli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: Where are we and where should we go?
- (2019) Qiuyao Huang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Niclosamide reverses adipocyte induced epithelial-mesenchymal transition in breast cancer cells via suppression of the interleukin-6/STAT3 signalling axis
- (2019) Jones Gyamfi et al. Scientific Reports
- Inhibition of Stat3 Signaling Pathway by Natural Product Pectolinarigenin Attenuates Breast Cancer Metastasis
- (2019) Yali Li et al. Frontiers in Pharmacology
- Small molecule STAT3 inhibitor, 6Br-6a suppresses breast cancer growth in vitro and in vivo
- (2019) Zhe Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- 2-Phenylnaphthyridin-4-one Derivative LYF-11 Inhibits Interleukin-6-mediated Epithelial–to– Mesenchymal Transition via the Inhibition of JAK2/STAT3 Signaling Pathway in MCF-7 Cells
- (2018) ANTICANCER RESEARCH
- Mechanisms of immune evasion in breast cancer
- (2018) Joshua P. Bates et al. BMC CANCER
- A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation
- (2018) Joyce O’Shaughnessy et al. BREAST CANCER RESEARCH AND TREATMENT
- Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer
- (2018) Yunhui Hu et al. CANCER LETTERS
- Transcriptional repression of HER2 by ClC-3 Cl- /H+ transporter inhibition in human breast cancer cells
- (2018) Mayu Fujimoto et al. CANCER SCIENCE
- JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance
- (2018) Tianyi Wang et al. Cell Metabolism
- Breast cancer bone metastases: pathogenesis and therapeutic targets
- (2018) Naomi Brook et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
- (2018) Eunhye Oh et al. INTERNATIONAL JOURNAL OF CANCER
- IL-6 and IL-8 Serum Levels Predict Tumor Response and Overall Survival after TACE for Primary and Secondary Hepatic Malignancies
- (2018) Sven Loosen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells
- (2018) Hauke Löcken et al. JOURNAL OF NATURAL PRODUCTS
- Catechol derived from aronia juice through lactic acid bacteria fermentation inhibits breast cancer stem cell formation via modulation Stat3/IL-6 signaling pathway
- (2018) Hack S. Choi et al. MOLECULAR CARCINOGENESIS
- FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome
- (2018) Robert Q. Le et al. ONCOLOGIST
- Interleukin-6 receptor inhibitor suppresses bone metastases in a breast cancer cell line
- (2018) Hiroki Wakabayashi et al. Breast Cancer
- Interleukin-6/STAT3 signalling regulates adipocyte induced epithelial-mesenchymal transition in breast cancer cells
- (2018) Jones Gyamfi et al. Scientific Reports
- GRAMD1B regulates cell migration in breast cancer cells through JAK/STAT and Akt signaling
- (2018) Puja Khanna et al. Scientific Reports
- Tagalide A and tagalol A, naturally occurring 5/6/6/6- and 5/6/6-fused cyclic dolabrane-type diterpenes: a new insight into the anti-breast cancer activity of the dolabrane scaffold
- (2018) Xiao-Hui Zhang et al. Organic Chemistry Frontiers
- Bioassay-guided isolation of cantharidin from blister beetles and its anticancer activity through inhibition of epidermal growth factor receptor-mediated STAT3 and Akt pathways
- (2018) Jaemoo Chun et al. Journal of Natural Medicines
- Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway
- (2018) Chuanlan Liu et al. PHYTOTHERAPY RESEARCH
- The molecular details of cytokine signalling via the JAK/STAT pathway
- (2018) Rhiannon Morris et al. PROTEIN SCIENCE
- Ganoderic acid A exerts antitumor activity against MDA‑MB‑231 human breast cancer cells by inhibiting the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway
- (2018) Yuguang Yang et al. Oncology Letters
- Adjuvant therapy with stattic enriches the anti-proliferative effect of doxorubicin in human ZR-75-1 breast cancer cells via arresting cell cycle and inducing apoptosis
- (2018) Fatemeh khaki-khatibi et al. BIOMEDICINE & PHARMACOTHERAPY
- FDA Approval Summary: Pertuzumab for adjuvant treatment of HER2-positive early breast cancer
- (2018) Lynn J. Howie et al. CLINICAL CANCER RESEARCH
- Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer
- (2018) Lanyun Feng et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- DT-13 suppresses breast cancer metastasis by modulating PLOD2 in the adipocytes microenvironment
- (2018) Jinyong He et al. PHYTOMEDICINE
- Methylseleninic Acid Suppresses Breast Cancer Growth via the JAK2/STAT3 Pathway
- (2018) Changwei Qiu et al. Reproductive Sciences
- Soluble gp130 prevents interleukin-6 and interleukin-11 cluster signaling but not intracellular autocrine responses
- (2018) Larissa Lamertz et al. Science Signaling
- Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer
- (2017) Marcela Moisés Maluf Sanguinete et al. IMMUNOLOGICAL INVESTIGATIONS
- A Second-Generation Proteasome Inhibitor and Doxorubicin Modulates IL-6, pSTAT-3 and NF-kB Activity in MDA-MB-231 Breast Cancer Cells
- (2017) Dinesh Vyas et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Precise discovery of a STAT3 inhibitor from Eupatorium lindleyanum and evaluation of its activity of anti-triple-negative breast cancer
- (2017) Bo Yang et al. NATURAL PRODUCT RESEARCH
- Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis
- (2017) Philip Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
- (2017) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- CGI-99 promotes breast cancer metastasis via autocrine interleukin-6 signaling
- (2017) C Lin et al. ONCOGENE
- Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study
- (2017) Nicolino Ruperto et al. Pediatric Rheumatology
- Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation
- (2017) Zong-Lin Zhang et al. Breast Cancer
- Interleukin-6 Family Cytokines
- (2017) Stefan Rose-John Cold Spring Harbor Perspectives in Biology
- Betulinic acid impairs metastasis and reduces immunosuppressive cells in breast cancer models
- (2017) An-Qi Zeng et al. Oncotarget
- Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study
- (2017) Qi Wu et al. Oncotarget
- Tocilizumab (Actemra)
- (2017) Martin Sheppard et al. Human Vaccines & Immunotherapeutics
- Interleukin-6 Trans-Signaling Pathway Promotes Immunosuppressive Myeloid-Derived Suppressor Cells via Suppression of Suppressor of Cytokine Signaling 3 in Breast Cancer
- (2017) Mengmeng Jiang et al. Frontiers in Immunology
- IL-6 variant is associated with metastasis in breast cancer patients
- (2017) Chike O. Abana et al. PLoS One
- Interleukins 1 and 6 as main mediators of inflammation and cancer
- (2016) O. S. Dmitrieva et al. BIOCHEMISTRY-MOSCOW
- IL-1β induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells
- (2016) Keunhee Oh et al. BMC CANCER
- Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study
- (2016) André Hennigs et al. BMC CANCER
- A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors
- (2016) Haihong Zhong et al. CANCER RESEARCH
- A novel IL-23p19/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice
- (2016) Xiaoqian Wang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Chikusetsusaponin IVa Butyl Ester (CS-IVa-Be), a Novel IL6R Antagonist, Inhibits IL6/STAT3 Signaling Pathway and Induces Cancer Cell Apoptosis
- (2016) Jie Yang et al. MOLECULAR CANCER THERAPEUTICS
- Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
- (2016) Sylvia Heink et al. NATURE IMMUNOLOGY
- Interleukin-6 receptor in spindle-shaped stromal cells, a prognostic determinant of early breast cancer
- (2016) Vivian Labovsky et al. TUMOR BIOLOGY
- Modeling anti-IL-6 therapy using breast cancer patient-derived xenografts
- (2016) Beatriz Morancho et al. Oncotarget
- Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models
- (2016) Adam R. Wolfe et al. Oncotarget
- Cleavage Site Localization Differentially Controls Interleukin-6 Receptor Proteolysis by ADAM10 and ADAM17
- (2016) Steffen Riethmueller et al. Scientific Reports
- Impact of breast cancer subtypes and patterns of metastasis on outcome
- (2015) Karin Kast et al. BREAST CANCER RESEARCH AND TREATMENT
- STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis
- (2015) Laura M. Jones et al. CANCER RESEARCH
- Association Between Ligands and Receptors Related to the Progression of Early Breast Cancer in Tumor Epithelial and Stromal Cells
- (2015) Vivian Labovsky et al. Clinical Breast Cancer
- FDA Approval: Siltuximab for the Treatment of Patients with Multicentric Castleman Disease
- (2015) A. Deisseroth et al. CLINICAL CANCER RESEARCH
- Interleukin-6: Biology, signaling and strategies of blockade
- (2015) Fred Schaper et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Inhibition of the autocrine IL-6–JAK2–STAT3–calprotectin axis as targeted therapy for HR−/HER2+breast cancers
- (2015) Ruth Rodriguez-Barrueco et al. GENES & DEVELOPMENT
- Elevated STAT3 Signaling-Mediated Upregulation of MMP-2/9 Confers Enhanced Invasion Ability in Multidrug-Resistant Breast Cancer Cells
- (2015) Fei Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ADAM17 controls IL-6 signaling by cleavage of the murine IL-6Rα from the cell surface of leukocytes during inflammatory responses
- (2015) Isabell Yan et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer
- (2015) R Bharti et al. ONCOGENE
- STAT3 integrates cooperative Ras and TGF-β signals that induce Snail expression
- (2015) M Saitoh et al. ONCOGENE
- Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels
- (2015) Tomofumi Miura et al. PANCREAS
- The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease
- (2015) Beata Kotowicz et al. TUMOR BIOLOGY
- Interleukin-6 and pro inflammatory status in the breast tumor microenvironment
- (2015) Alessandro Sanguinetti et al. World Journal of Surgical Oncology
- Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model
- (2015) F Yang et al. Cell Death & Disease
- Stat3 orchestrates interaction between endothelial and tumor cells and inhibition of Stat3 suppresses brain metastasis of breast cancer cells
- (2015) Hsueh-Te Lee et al. Oncotarget
- A Novel Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Activities and Exhibits Potent Growth-Suppressive Activity in Human Cancer Cells
- (2015) Li Lin et al. NEOPLASIA
- The IL-6/JAK/Stat3 Feed-Forward Loop Drives Tumorigenesis and Metastasis
- (2015) Qing Chang et al. NEOPLASIA
- Drug Design Targeting Protein–Protein Interactions (PPIs) Using Multiple Ligand Simultaneous Docking (MLSD) and Drug Repositioning: Discovery of Raloxifene and Bazedoxifene as Novel Inhibitors of IL-6/GP130 Interface
- (2014) Huameng Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- IL-6 trans-Signaling-Dependent Rapid Development of Cytotoxic CD8+ T Cell Function
- (2014) Jan P. Böttcher et al. Cell Reports
- Ado-trastuzumab emtansine (T-DM1): a novel antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer
- (2014) Jessica M Baron et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- STAT3 Target Genes Relevant to Human Cancers
- (2014) Richard Carpenter et al. Cancers
- Soluble Interleukin-6 Receptor is a Prognostic Marker for Relapse-Free Survival in Estrogen Receptor-Positive Breast Cancer
- (2013) Hye Sung Won et al. CANCER INVESTIGATION
- STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits
- (2013) SEYUNG S. CHUNG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus
- (2013) Miao-Fen Chen et al. Molecular Cancer
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Deguelin Action Involves c-Met and EGFR Signaling Pathways in Triple Negative Breast Cancer Cells
- (2013) Rajeshwari Mehta et al. PLoS One
- Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy
- (2012) Chin Hao Chang et al. INTERNATIONAL JOURNAL OF CANCER
- Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population
- (2012) Hasan Korkaya et al. MOLECULAR CELL
- The composition and signaling of the IL-35 receptor are unconventional
- (2012) Lauren W Collison et al. NATURE IMMUNOLOGY
- A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
- (2012) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures
- (2011) Yawei Yuan INTERNATIONAL JOURNAL OF ONCOLOGY
- The Selective Estrogen Receptor Modulator Bazedoxifene Inhibits Hormone-Independent Breast Cancer Cell Growth and Down-Regulates Estrogen Receptor and Cyclin D1
- (2011) J. S. Lewis-Wambi et al. MOLECULAR PHARMACOLOGY
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- FDA approves tocilizumab to treat rheumatoid arthritis
- (2010) C. A. Thompson AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- A novel small-molecule inhibitor of IL-6 signalling
- (2010) Giovanna Zinzalla et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
- (2010) L. Lin et al. CANCER RESEARCH
- IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer
- (2010) Chi-Wen Lo et al. CANCER RESEARCH
- Constitutively Active Stat3 Enhances Neu-Mediated Migration and Metastasis in Mammary Tumors via Upregulation of Cten
- (2010) I. Barbieri et al. CANCER RESEARCH
- Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells
- (2010) J. Lee et al. CARCINOGENESIS
- Interleukin-6 in bone metastasis and cancer progression
- (2010) Tasnim Ara et al. EUROPEAN JOURNAL OF CANCER
- The soluble Interleukin 6 receptor: Generation and role in inflammation and cancer
- (2010) Athena Chalaris et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Analysis of the Effect of Serum Interleukin-6 (IL-6) and Soluble IL-6 Receptor Levels on Survival of Patients with Colorectal Cancer
- (2010) K.-Y. Yeh et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Naphtho[1,2-b]furan-4,5-dione disrupts Janus kinase-2 and induces apoptosis in breast cancer MDA-MB-231 cells
- (2010) Kuei-Li Lin et al. TOXICOLOGY IN VITRO
- Host Genetic Variants in the Interleukin-6 Promoter Predict Poor Outcome in Patients with Estrogen Receptor-Positive, Node-Positive Breast Cancer
- (2009) A. DeMichele et al. CANCER RESEARCH
- An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
- (2009) Dimitrios Iliopoulos et al. CELL
- Serum interleukin-6 and -10 levels in patients with gastric cancer
- (2009) Masahide Ikeguchi et al. Gastric Cancer
- Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells
- (2009) N J Sullivan et al. ONCOGENE
- Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells
- (2009) M Walter et al. ONCOGENE
- STAT3 can be activated through paracrine signaling in breast epithelial cells
- (2008) Jacqueline C Lieblein et al. BMC CANCER
- CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells
- (2008) Zhenfeng Duan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Fibroblasts Isolated from Common Sites of Breast Cancer Metastasis Enhance Cancer Cell Growth Rates and Invasiveness in an Interleukin-6–Dependent Manner
- (2008) Adam W. Studebaker et al. CANCER RESEARCH
- Role of Stat3 in suppressing anti-tumor immunity
- (2008) Marcin Kortylewski et al. CURRENT OPINION IN IMMUNOLOGY
- Raloxifene in breast cancer prevention
- (2008) Luigi Gennari et al. Expert Opinion On Drug Safety
- The NSABP Study of Tamoxifen and Raloxifene (STAR) trial
- (2008) Victor G Vogel Expert Review of Anticancer Therapy
- Protein tyrosine phosphatases in the JAK/STAT pathway
- (2008) Dan Xu Frontiers in Bioscience-Landmark
- Stat3 mediates myeloid cell–dependent tumor angiogenesis in mice
- (2008) Maciej Kujawski et al. JOURNAL OF CLINICAL INVESTIGATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started